Home » Topics » BioWorld Science

BioWorld Science
RSS

Immunity-related pathways contribute to the genetic burden of asthma pathology, new GWAS shows

May 14, 2020

Copper escort alleviates Menkes disease

May 14, 2020

New compounds target SARS-CoV-2 main protease Mpro

May 13, 2020

TransThera studies TT-00920 for heart failure in first-in-human study

May 13, 2020

Veru cleared by FDA to begin phase II study of VERU-111 for COVID-19

May 13, 2020

Arrowhead opens enrollment in phase Ib study of ARO-HIF2 in advanced clear cell renal cell carcinoma

May 13, 2020

Genocea eyes IND filing for neoantigen cell therapy GEN-011

May 13, 2020

Blade Therapeutics begins phase II study of BLD-2660 in hospitalized patients with COVID-19

May 13, 2020

New biomarker identified for the aging brain

May 13, 2020

C4X Discovery Holdings presents NFE2-related factor 2 activators

May 13, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.